Top Tweets for #CookMedicalDES
ICYMI: Prediction model presented at #CIRSE2020 highlights transparency in patient outcomes with Zilver PTX. Read full press release here: https://t.co/SpkyT1BEWV @cirsesociety #irad #CookMedicalDES

ICYMI: Prediction model presented at #CIRSE2020 highlights transparency in patient outcomes with Zilver PTX. Read full press release here: https://t.co/SpkyT1BEWV @cirsesociety #irad #CookMedicalDES

Interesting discussion this morning at #CIRSE2020 on safety of drug-based technology. Read here about safety of #ZilverPTX and request de-identified patient-level RCT data. ➡️ https://t.co/IojCiyA4q0 @cirsesociety #irad #CookMedicalDES
Dr. Michael Dake: Patient & lesion factors from 5 global clinical studies used to develop a prediction model for freedom from TLR through 5 years for PAD patients treated with #CookMedicalDES. Visit the interactive tool. ➡️ https://t.co/EbVzSKRqku #CIRSE2020 @cirsesociety #irad

For more information on #CookMedicalDES patient-level data used in Dr. Michael Dake's #CIRSE2020 presentation, visit https://t.co/Ay3VYz7ePN. #paclitaxel @cirsesociety #irad

Dr. Michael Dake on #paclitaxel and mortality: Mortality rate decreases w/fewer risk factors. Combinations of risk factors more prevalent in #CookMedicalDES primary randomization group (p<0.01). Actual treatment showed no mortality signal. #CIRSE2020 @cirsesociety #irad

Dr. Gary Ansel: "Would we even be having this conversation" about #paclitaxel and mortality if we had appropriately analyzed the #CookMedicalDES secondary randomization with actual treatment vs intent to treat? #CX2020 @CXSymposium.

See our de-identified patient-level data for the Zilver PTX Randomized Controlled Trial. The only modifications we’ve made to this data are designed to guarantee that patient privacy & confidentiality are always protected. https://t.co/c6TWYO7Lje #CookMedicalDES

New 5 mm diameter #CookMedicalDES expands @cookmedical offering of broadest range of drug-eluting stent sizes available to treat PAD in SFA. Read more. https://t.co/058PmWkc0P
It's been 1 year since controversial meta-analysis rocked the endovascular world. Because patients always come first, we provided de-identified patient-level data in spirit of transparency. See #CookMedicalDES presentations & journal articles. https://t.co/Qz7q7sKHKd #paclitaxel

On Jan. 10, 2019, Dr. Robert Beasley, director of Mount Sinai’s Vascular/Interventional Radiology Lab and Evanescence Vein Center, became the first U.S. physician to use a 5 mm DES. Read more. https://t.co/LPAKkNK47Z #CookMedicalDES @DrBobBeasley @MountSinaiIR

News: Cook Medical DES vs. Bypass surgery. https://t.co/gMvHbuRh8P #CookMedicalDES

Dr. Michael Dake on #CookMedicalDES -- Vital status through 5 years for 94% of patients. Intent-to-treat: no significant difference in mortality; imbalance in risk factors (p<0.01), despite randomization. #paclitaxel #VEITH2019 @VEITHsymposium

ICYMI: According to Dr. Marc Bosiers, data from ZILVERPASS study show #CookMedicalDES leads to fewer complications and shorter hospital stays than traditional bypass surgery. Read more ➡️ https://t.co/8eh8DIb58Z
Dr. Dake: 40% of patients in PTA primary randomization group treated w/ #CookMedicalDES. No mortality signal. Cook DES shows benefit across different risk factor groups. Greater relative benefit observed in groups w/ fewer risk factors. #VEITH2019 @VEITHsymposium #paclitaxel

Breaking news: According to Dr. Marc Bosiers, data from ZILVERPASS study show #CookMedicalDES leads to fewer complications and shorter hospital stays than traditional bypass surgery. Read more ➡️ https://t.co/8eh8DIb58Z #VEITH2019 @VEITHsymposium

Dr. Kimihiro Komori: #CookMedicalDES results from Japan PMS, which includes challenging patient subgroups often excluded from clinical studies, are consistently good through 5 years. #VEITH2019 @VEITHsymposium

New 5 mm diameter #CookMedicalDES benefits patients with small vessels. Read more ➡️ https://t.co/KFNc5kJhT6 @DrBobBeasley
During Late-breaking Clinical Trials, Dr Michael Dake said recent data showed patients assigned to #CookMedicalDES RCT group had more risk factors than control group, despite trial’s randomization of patient assignment. https://t.co/aD6nUTYxGJ @vivaphysicians #paclitaxel #VIVA19

Last Seen Hashtags on Sotwe
Omegle
Seen from Brazil
Chudai
Seen from United States
novinhos midias
Seen from Brazil
anxiouspandaa
Seen from United States
minichat ()()()()()()()*****()******* filter:videos
Seen from United States
每日大赛
Seen from Netherlands
minichatt
Seen from Chile
minichatt()**** video
blackedwaifu
Seen from Brazil
gachasex #futa
Seen from United States
Most Popular Users

Elon Musk 
@elonmusk
241.5M followers

Barack Obama 
@barackobama
118.8M followers

Cristiano Ronaldo 
@cristiano
114.5M followers

Donald J. Trump 
@realdonaldtrump
111.9M followers

Narendra Modi 
@narendramodi
107.1M followers

Rihanna 
@rihanna
98.7M followers

NASA 
@nasa
92.3M followers

Justin Bieber 
@justinbieber
91.8M followers

KATY PERRY 
@katyperry
90M followers

Taylor Swift 
@taylorswift13
84M followers

Lady Gaga 
@ladygaga
75.5M followers

Virat Kohli 
@imvkohli
73.5M followers

Kim Kardashian 
@kimkardashian
70.9M followers

YouTube 
@youtube
68.8M followers

Neymar Jr 
@neymarjr
66.5M followers

Bill Gates 
@billgates
65.3M followers

Selena Gomez 
@selenagomez
63.1M followers

The Ellen Show
@theellenshow
62.2M followers

CNN 
@cnn
61.7M followers

X 
@x
60.7M followers

